Barriers to and facilitators of living guidelines use in low-income and middle-income countries: a scoping review
Introduction Living guidelines provide reliable, ongoing evidence surveillance and regularly
updated recommendations for healthcare decision-making. As a relatively new concept …
updated recommendations for healthcare decision-making. As a relatively new concept …
Community antibiotic prescribing in patients with COVID-19 across three pandemic waves: a population-based study in Scotland, UK
L Ciaccio, PT Donnan, BJ Parcell, CA Marwick - BMJ open, 2024 - bmjopen.bmj.com
Objectives This study aims to examine community antibiotic prescribing across a complete
geographical area for people with a positive COVID-19 test across three pandemic waves …
geographical area for people with a positive COVID-19 test across three pandemic waves …
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome …
A Di Lorenzo, L Campogiani, M Iannetta, R Iannazzo… - Antibiotics, 2023 - mdpi.com
Co-infections during COVID-19 may worsen patients' outcomes. This study reports the
results of a screening assessing the presence of co-infections among patients hospitalized …
results of a screening assessing the presence of co-infections among patients hospitalized …
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study
M Rinaldi, C Campoli, M Gallo, D Marzolla… - BMC Infectious …, 2023 - Springer
Purpose To investigate the clinical impact of three available antivirals for early COVID-19
treatment in a large real-life cohort. Methods Between January and October 2022 all …
treatment in a large real-life cohort. Methods Between January and October 2022 all …
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
E Leegwater, L Dol, MR Benard, EE Roelofsen… - Infectious Diseases and …, 2023 - Springer
Introduction Remdesivir is a registered treatment for hospitalised patients with COVID-19
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
that has moderate clinical effectiveness. Anecdotally, some patients' respiratory insufficiency …
Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients
M Lucijanic, P Bistrovic - Clinical …, 2022 - clinicalmicrobiologyandinfection …
We have read with great interest the recent comment by Dr Dauby considering
cardiovascular side effects of remdesivir [1] that might call into question its role in the …
cardiovascular side effects of remdesivir [1] that might call into question its role in the …
Clostridioides Difficile: A Concise Review of Best Practices and Updates
A Yakout, Y Bi, DM Harris - Journal of Primary Care & …, 2024 - journals.sagepub.com
Clostridioides difficile infection (CDI) is one of the most common and severe nosocomial
infections worldwide. It can also affect healthy individuals in the community. The incidence of …
infections worldwide. It can also affect healthy individuals in the community. The incidence of …
Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot …
BG Szabó, P Reményi, S Tasnády, D Korózs… - Journal of Clinical …, 2023 - mdpi.com
Background: The optimal approach for adult patients hospitalized with severe and critical
coronavirus disease 2019 (COVID-19), non-responsive to antiviral and immunomodulatory …
coronavirus disease 2019 (COVID-19), non-responsive to antiviral and immunomodulatory …
Case report: Enhancing prognosis in severe COVID-19 through human herpes virus coinfection treatment strategies
Y Lu, C Wang, Y Wang, Y Chen, L Zhao… - Frontiers in Cellular and …, 2024 - frontiersin.org
Background In the context of increasing reports of co-infection with coronavirus disease
2019 (COVID-19), particularly with human herpes viruses (HHVs), it is important to consider …
2019 (COVID-19), particularly with human herpes viruses (HHVs), it is important to consider …
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study
A Oliva, F Cogliati Dezza, F Petrucci… - Clinical and …, 2023 - Springer
Patients with haematological malignancies (HM) and SARS-CoV-2 infection present a
higher risk of severe COVID-19 and mortality. The aim of the study was to investigate …
higher risk of severe COVID-19 and mortality. The aim of the study was to investigate …